NuMedii Competitors and Similar CompaniesClear all
NuMedii's competitors and similar companies include Neo-science Group, Tiziana Life Sciences, Voyager Therapeutics and Enzo Biochem.
 NuMedii NuMedii discovers and de-risks effective drugs by translating life sciences big data into therapies. |  Neo-science Group Neo-Science and Group is a company that offers high-quality solutions and services to the clinical and scientific. |  Tiziana Life Sciences Tiziana Life Sciences PLC is a clinical-stage biotechnology company. The Company is focused on targeted drugs to treat diseases in oncology and immunology, with a focus on metastatic cancers. |  Voyager Therapeutics Voyager Therapeutics is a gene therapy company developing treatments for diseases of the central nervous system (CNS). |  Enzo Biochem Enzo Biochem is a biotechnology company specializing in the research, development, manufacturing, and marketing of diagnostic and research products that utilize genetic engineering, biotechnology, and molecular biology. | |
Founding Date | Founding Date 2008 | Founding Date N/A | Founding Date 2013 | Founding Date 2014 | Founding Date 1976 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations San Mateo, US HQ | Locations Dubai, AE HQ | Locations London, GB HQ Doylestown, US New York, US | Locations Cambridge, US HQ | Locations Farmingdale, US HQ Lausen, CH Ann Arbor, US Farmingdale, US |
Employees | Employees 5 | Employees 166% decrease | Employees 9 | Employees 16230% increase | Employees 12530% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 157.3 m | Valuation ($) 382.8 m | Valuation ($) 58.1 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $40.4m (FY, 2025) | Revenue (est.) $31.9m (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $17.3m (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $14.6m (FY, 2024) |
Net income | Net income N/A | Net income N/A | Net income (£20.3m) (FY, 2020) | Net income ($119.7m) (FY, 2025) | Net income ($26.1m) (FY, 2024) |
Operating ⚠ | |||||
Patents Issued | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A | Patents Issued 229 (FY, 2021) | Patents Issued 314 (FY, 2016) |
Funding | |||||
Total funding raised | Total funding raised $ 5.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 135m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Neo-science Group
HQ
Dubai, AE
Employees
16↓ 6% decrease
Neo-Science and Group is a company that offers high-quality solutions and services to the clinical and scientific.
View companyTiziana Life Sciences
HQ
London, GB
Employees
9
Tiziana Life Sciences PLC is a clinical-stage biotechnology company. The Company is focused on targeted drugs to treat diseases in oncology and immunology, with a focus on metastatic cancers.
View companyVoyager Therapeutics
HQ
Cambridge, US
Employees
162↑ 30% increase
Voyager Therapeutics is a gene therapy company developing treatments for diseases of the central nervous system (CNS).
View companyEnzo Biochem
HQ
Farmingdale, US
Employees
125↓ 30% decrease
Enzo Biochem is a biotechnology company specializing in the research, development, manufacturing, and marketing of diagnostic and research products that utilize genetic engineering, biotechnology, and molecular biology.
View company